Viasat Introduces Air-IQ: the Next-generation of Smarter, Flexible ISR Connectivity for Mission Operations
New portfolio will offer a faster and more intelligent airborne ISR solution with guaranteed availability and scalability to meet mission demands anywhere in the world CARLSBAD, Calif. and FARNBOROUGH, England, July 23, 2024 /PRNewswire/ — Viasat Inc. (NASDAQ: VSAT), a global leader in satell
Beeline Elevates Manfred Vogels to Vice President, EMEA Markets
Executive Leadership Role to Drive Beeline’s Commitment to Increased Regional Growth, Innovation, and Strategic Vision JACKSONVILLE, Fla., July 23, 2024 /PRNewswire/ — Beeline, the leader in global extended workforce management technology, is thrilled to announce the promotion of Manfr
UPM Half-Year Financial Report 2024: Comparable EBIT increased by 60% in Q2, UPM Paso de los Toros reached full capacity
UPM-Kymmene Corporation Stock Exchange Release (Half-Year Financial Report) 23 July 2024 at 09:30 EEST HELSINKI, July 23, 2024 /PRNewswire/ — UPM Half-Year Financial Report 2024:Comparable EBIT increased by 60% in Q2, UPM Paso de los Toros reached full capacity Q2 2024 highlights Sales total
Global Times: China’s young table tennis aces are poised to defend their nation’s legacy in the sport amid stiff competition
BEIJING, July 23, 2024 /PRNewswire/ — Considered as the national sport of China, table tennis is a sport in which the Chinese national team has historically excelled at the Olympic Games. China finished the 2020 Tokyo Olympics with four gold and three silver medals, losin
Nidec Executes a Comprehensive MOU with Tata Elxsi Ltd.
KYOTO, Japan and BENGALURU, India, July 23, 2024 /PRNewswire/ — Nidec Corporation (TSE: 6594) (OTC US: NJDCY) (“Nidec” or the “Company”) today announced that it has executed a memorandum of understanding (the “MOU”) on July 22, 2024 with India’s Tata E
Diamyd Medical receives positive feedback from FDA on potential Accelerated Approval for Diamyd® in Type 1 Diabetes
STOCKHOLM , July 23, 2024 /PRNewswire/ — Diamyd Medical received encouraging feedback from the U.S. Food and Drug Administration (FDA) regarding an Accelerated Approval pathway for its immunotherapy, Diamyd®, for treating patients with Stage 3 Type 1 Diabetes carrying the genotype HLA DR3-D
Diamyd Medical receives positive feedback from FDA on potential Accelerated Approval for Diamyd® in Type 1 Diabetes
STOCKHOLM , July 23, 2024 /PRNewswire/ — Diamyd Medical received encouraging feedback from the U.S. Food and Drug Administration (FDA) regarding an Accelerated Approval pathway for its immunotherapy, Diamyd®, for treating patients with Stage 3 Type 1 Diabetes carrying the genotype HLA DR3-D
Nidec Executes a Comprehensive MOU with Tata Elxsi Ltd.
KYOTO, Japan and BENGALURU, India, July 23, 2024 /PRNewswire/ — Nidec Corporation (TSE: 6594) (OTC US: NJDCY) (“Nidec” or the “Company”) today announced that it has executed a memorandum of understanding (the “MOU”) on July 22, 2024 with India’s Tata E
Xinhua Silk Road: Young people from 16 foreign countries join Shanghai Int’l Sister Cities Youth Camp to experience Chinese culture
BEIJING, July 23, 2024 /PRNewswire/ — The 2024 Shanghai International Sister Cities Youth Camp, hosted by Putuo District Education Bureau, was held in Shanghai from July 3 to 16. Themed on “Communication, Cooperation, Friendship and Understanding”, this year’s event attracte
XRP Healthcare Halts New Staking of XRPH Token to Preserve Finite Supply, Shifts Focus to Real-World Healthcare Ventures
DUBAI, UAE, July 23, 2024 /PRNewswire/ — XRP Healthcare, a pioneering company integrating blockchain technology with healthcare services, has announced the cessation of new staking activities for its XRPH token. This strategic move aims to safeguard the finite supply of the token, which was bl
